EA
AGTC

Emerald Acquisition’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Emerald Acquisition’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.48M Buy
151,413
+25,283
+20% +$341K ﹤0.01% 1915
2016
Q2 		$1.78M Buy
+126,130
New +$1.97M ﹤0.01% 1891

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's AGTC Position: Q3 2016 in Review

Emerald Acquisition increased its Applied Genetic Technologies Corporation (AGTC) stake by 20% in Q3 2016, buying an estimated $341K and bringing the position to 151,413 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1915.

Emerald Acquisition first reported a position in AGTC in Q2 2016 and has held it in 2 quarters since. The position peaked at $1.78M in Q2 2016. 95 funds tracked by Wall St. Rank hold AGTC as of Q3 2016.

  • Emerald Acquisition held 151,413 shares of Applied Genetic Technologies Corporation worth $1.48M as of Q3 2016.
  • Emerald Acquisition bought 25,283 Applied Genetic Technologies Corporation shares in Q3 2016, an estimated $341K.
  • Applied Genetic Technologies Corporation made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1915 holding.
  • Emerald Acquisition first reported a position in Applied Genetic Technologies Corporation in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Applied Genetic Technologies Corporation position peaked at $1.78M in Q2 2016.
  • 95 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.